Another study reveals that the inhibition of Kif15 in human HCC xenograft models delays the invasive and proliferative ability of tumors via increasing intracellular reactive oxygen species (ROS) levels (Li et al., 2020). Here, KIF15 is linked to hepatocellular carcinoma.